Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Ryan

Showing results (261-270 of 269) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 269 results.
Annals of Surgical Oncology|April 5, 2014
The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot studyKhairun I Abdul-Jalil, Katherine M Sheehan, Sinead Toomey, et al.
Journal of Medicinal Chemistry|November 14, 2024
Discovery and Optimization of First-in-Class Molecular Glue Degraders of the WIZ Transcription Factor for Fetal Hemoglobin Induction to Treat Sickle Cell DiseaseJohn Ryan Kerrigan, Noel M Thomsen, Artiom Cernijenko, et al.
Hepatology International|March 29, 2018
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotypePaul Adams, Albert Altes, Pierre Brissot, et al.
Lancet (London, England)|November 14, 2021
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trialRajeka Lazarus, Sarah Baos, Heike Cappel-Porter, et al.
Blood|July 15, 2021
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar StudyCorey Cutler, Stephanie J Lee, Sally Arai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 13, 2024
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Science (New York, N.Y.)|July 4, 2024
A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin inductionPamela Y Ting, Sneha Borikar, John Ryan Kerrigan, et al.
Gastroenterology|October 16, 2024
Longitudinal Evaluation of Individuals With Severe Alpha-1 Antitrypsin Deficiency (Pi∗ZZ Genotype)Malin Fromme, Audrey Payancé, Mattias Mandorfer, et al.
Annals of the Rheumatic Diseases|June 30, 2026
Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts projectAnna Moltó, Anastasiia Miendrova, Laure Gossec, et al.
Pageof 27

Showing results (261-270 of 269) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 269 results.
Annals of Surgical Oncology|April 5, 2014
The frequencies and clinical implications of mutations in 33 kinase-related genes in locally advanced rectal cancer: a pilot studyKhairun I Abdul-Jalil, Katherine M Sheehan, Sinead Toomey, et al.
Journal of Medicinal Chemistry|November 14, 2024
Discovery and Optimization of First-in-Class Molecular Glue Degraders of the WIZ Transcription Factor for Fetal Hemoglobin Induction to Treat Sickle Cell DiseaseJohn Ryan Kerrigan, Noel M Thomsen, Artiom Cernijenko, et al.
Hepatology International|March 29, 2018
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotypePaul Adams, Albert Altes, Pierre Brissot, et al.
Lancet (London, England)|November 14, 2021
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trialRajeka Lazarus, Sarah Baos, Heike Cappel-Porter, et al.
Blood|July 15, 2021
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar StudyCorey Cutler, Stephanie J Lee, Sally Arai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 13, 2024
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024John A Thompson, Bryan J Schneider, Julie Brahmer, et al.
Science (New York, N.Y.)|July 4, 2024
A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin inductionPamela Y Ting, Sneha Borikar, John Ryan Kerrigan, et al.
Gastroenterology|October 16, 2024
Longitudinal Evaluation of Individuals With Severe Alpha-1 Antitrypsin Deficiency (Pi∗ZZ Genotype)Malin Fromme, Audrey Payancé, Mattias Mandorfer, et al.
Annals of the Rheumatic Diseases|June 30, 2026
Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts projectAnna Moltó, Anastasiia Miendrova, Laure Gossec, et al.
Pageof 27